Difluoroethane toxicity: Difference between revisions
No edit summary |
|||
| (9 intermediate revisions by the same user not shown) | |||
| Line 4: | Line 4: | ||
*Though considered non-toxic for industrial use, DFE is increasingly recognized as a substance of abuse, especially among adolescents and young adults, due to its rapid-onset euphoric effects when inhaled—a practice known as "huffing." | *Though considered non-toxic for industrial use, DFE is increasingly recognized as a substance of abuse, especially among adolescents and young adults, due to its rapid-onset euphoric effects when inhaled—a practice known as "huffing." | ||
== Key Pearls == | ===Key Pearls=== | ||
* Sudden cardiac death from DFE abuse can occur in previously healthy individuals. | * Sudden cardiac death from DFE abuse can occur in previously healthy individuals. | ||
* Always obtain an EKG and initiate cardiac monitoring. | * Always obtain an EKG and initiate cardiac monitoring. | ||
| Line 12: | Line 12: | ||
=== Pathophysiology === | === Pathophysiology === | ||
*Rapidly absorbed through the lungs | |||
*Acts primarily as a CNS depressant | |||
**Volatile properties and lipid solubility allow it to penetrate the brain quickly, producing an intoxicating effect within seconds of inhalation. | |||
Key pathophysiologic effects: | Key pathophysiologic effects: | ||
* Sensitization of myocardium to catecholamines → increased risk of fatal arrhythmias ("sudden sniffing death") | * Sensitization of myocardium to catecholamines → increased risk of fatal arrhythmias ("sudden sniffing death") | ||
* Hypoxia and asphyxia due to displacement of alveolar oxygen | * Hypoxia and asphyxia due to displacement of alveolar oxygen | ||
| Line 23: | Line 25: | ||
== Clinical Features == | == Clinical Features == | ||
=== Acute Presentation | === Acute Presentation === | ||
* Euphoria, dizziness, slurred speech | * Euphoria, [[dizziness]], slurred speech | ||
* Confusion, ataxia, lethargy | * Confusion, ataxia, lethargy | ||
* Nausea, vomiting | * [[Nausea]], [[vomiting]] | ||
* Seizures, particularly in high-dose exposure | * [[Seizures]], particularly in high-dose exposure | ||
* Syncope or cardiac arrest (especially with exertion or catecholamine surge) | * [[Syncope]] or [[cardiac arrest]] (especially with exertion or catecholamine surge) | ||
=== Cardiac Effects === | === Cardiac Effects === | ||
* Palpitations | * [[Palpitations]] | ||
* Premature ventricular contractions (PVCs) | * [[Premature ventricular contractions]] (PVCs) | ||
* Ventricular tachycardia/fibrillation | * [[Ventricular tachycardia]]/fibrillation | ||
* QT prolongation, possibly torsades de pointes | * [[QT prolongation]], possibly [[torsades de pointes]] | ||
=== Pulmonary Effects === | === Pulmonary Effects === | ||
* Cough, dyspnea | * [[Cough]], [[dyspnea]] | ||
* Chemical pneumonitis | * Chemical pneumonitis | ||
* Pulmonary hemorrhage (in rare cases) | * [[Pulmonary hemorrhage]] (in rare cases) | ||
=== Chronic Use === | === Chronic Use === | ||
* Cognitive decline | * Cognitive decline | ||
* Peripheral neuropathy | * [[Peripheral neuropathy]] | ||
* Hepatotoxicity or nephrotoxicity | * Hepatotoxicity or nephrotoxicity | ||
* Dermal frostbite or oronasal irritation from direct contact with aerosol can | * Dermal [[frostbite]] or oronasal irritation from direct contact with aerosol can | ||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
{{Drugs of abuse types}} | |||
{{Toxic gas exposure DDX}} | |||
==Evaluation== | ==Evaluation== | ||
===Workup=== | ===Workup=== | ||
* | * [[ECG]]: assess for [[QT prolongation]], [[PVCs]], ventricular arrhythmias | ||
* Cardiac monitoring | * Cardiac monitoring | ||
* Chest X-ray if respiratory symptoms are present | * [[Chest X-ray]] if respiratory symptoms are present | ||
* Basic labs: | * Basic labs: | ||
** CBC, BMP, troponin | ** CBC, BMP, troponin | ||
** Creatinine kinase (CK) | ** Creatinine kinase (CK) | ||
** ABG if hypoxia suspected | ** [[ABG]] if hypoxia suspected | ||
** Urine toxicology screen: may not detect difluoroethane but can help rule out co-ingestions | ** [[Urine toxicology screen]]: may not detect difluoroethane but can help rule out co-ingestions | ||
===Diagnosis=== | ===Diagnosis=== | ||
* Consider DFE toxicity in any young patient with sudden unexplained arrhythmia, altered mental status, or seizure | * Consider DFE toxicity in any young patient with sudden unexplained arrhythmia, [[altered mental status]], or [[seizure]] | ||
* Ask about recent use of aerosol sprays, cleaning products, or refrigerants | * Ask about recent use of aerosol sprays, cleaning products, or refrigerants | ||
* Look for signs of inhalant abuse: | * Look for signs of [[inhalant abuse]]: | ||
** Chemical odor on breath | ** Chemical odor on breath | ||
** Perioral or hand burns | ** Perioral or hand burns | ||
| Line 70: | Line 74: | ||
==Management== | ==Management== | ||
Supportive Care | ===Supportive Care=== | ||
* Airway, breathing, circulation (ABCs) | * Airway, breathing, circulation (ABCs) | ||
* Supplemental oxygen as needed | * Supplemental [[oxygen]] as needed | ||
* Continuous cardiac monitoring due to risk of arrhythmia | * Continuous cardiac monitoring due to risk of [[arrhythmia]] | ||
* Avoid catecholamines (e.g., epinephrine, norepinephrine) unless absolutely necessary—may precipitate fatal arrhythmias | * Avoid catecholamines (e.g., [[epinephrine]], [[norepinephrine]]) unless absolutely necessary—may precipitate fatal arrhythmias | ||
Treat Complications | ===Treat Complications if Applicable=== | ||
* Ventricular arrhythmias → defibrillation, amiodarone (avoid lidocaine in some cases) | * Ventricular arrhythmias → [[defibrillation]], [[amiodarone]] (avoid [[lidocaine]] in some cases) | ||
* Seizures → benzodiazepines | * [[Seizures]] → [[benzodiazepines]] | ||
* Respiratory failure or chemical pneumonitis → consider intubation and supportive ventilation | * [[Respiratory failure]] or chemical pneumonitis → consider [[intubation]] and supportive ventilation | ||
* Skin or mucosal injury → treat as chemical burns or frostbite | * Skin or mucosal injury → treat as [[chemical burns]] or [[frostbite]] | ||
==Disposition== | ==Disposition== | ||
| Line 94: | Line 98: | ||
* No signs of pulmonary or neurologic complications | * No signs of pulmonary or neurologic complications | ||
==Referral Considerations=== | ====Referral Considerations==== | ||
* Substance abuse counseling or addiction medicine | * Substance abuse counseling or addiction medicine | ||
* Consider social work consult for adolescents or vulnerable individuals | * Consider social work consult for adolescents or vulnerable individuals | ||
Latest revision as of 23:04, 10 December 2025
Background
- Difluoroethane (DFE) is a hydrofluorocarbon (HFC) commonly used as a propellant in aerosol products, including computer keyboard cleaners and refrigerants.
- Though considered non-toxic for industrial use, DFE is increasingly recognized as a substance of abuse, especially among adolescents and young adults, due to its rapid-onset euphoric effects when inhaled—a practice known as "huffing."
Key Pearls
- Sudden cardiac death from DFE abuse can occur in previously healthy individuals.
- Always obtain an EKG and initiate cardiac monitoring.
- Do not rely on routine tox screens—DFE often won’t show up.
- Avoid exogenous catecholamines if arrhythmia risk is present.
- Suspect DFE in cases of unexplained syncope, seizures, or cardiac arrest—especially in youth or with aerosol products nearby
Pathophysiology
- Rapidly absorbed through the lungs
- Acts primarily as a CNS depressant
- Volatile properties and lipid solubility allow it to penetrate the brain quickly, producing an intoxicating effect within seconds of inhalation.
Key pathophysiologic effects:
- Sensitization of myocardium to catecholamines → increased risk of fatal arrhythmias ("sudden sniffing death")
- Hypoxia and asphyxia due to displacement of alveolar oxygen
- Central nervous system depression, including coma and seizures
- Pulmonary injury: inflammation, hemorrhage, and edema
- Hepatic and renal injury with chronic or massive exposure
Clinical Features
Acute Presentation
- Euphoria, dizziness, slurred speech
- Confusion, ataxia, lethargy
- Nausea, vomiting
- Seizures, particularly in high-dose exposure
- Syncope or cardiac arrest (especially with exertion or catecholamine surge)
Cardiac Effects
- Palpitations
- Premature ventricular contractions (PVCs)
- Ventricular tachycardia/fibrillation
- QT prolongation, possibly torsades de pointes
Pulmonary Effects
- Cough, dyspnea
- Chemical pneumonitis
- Pulmonary hemorrhage (in rare cases)
Chronic Use
- Cognitive decline
- Peripheral neuropathy
- Hepatotoxicity or nephrotoxicity
- Dermal frostbite or oronasal irritation from direct contact with aerosol can
Differential Diagnosis
Drugs of abuse
- 25C-NBOMe
- Alcohol
- Amphetamines
- Bath salts
- Cocaine
- Difluoroethane
- Ecstasy
- Gamma hydroxybutyrate (GHB)
- Heroin
- Inhalant abuse
- Hydrocarbon toxicity
- Difluoroethane (electronics duster)
- Marijuana
- Kratom
- Phencyclidine (PCP)
- Psilocybin ("magic mushrooms")
- Synthetic cannabinoids
- Chloral hydrate
- Body packing
Toxic gas exposure
- Carbon monoxide toxicity
- Chemical weapons
- Cyanide toxicity
- Dichloromethane toxicity
- Hydrocarbon toxicity
- Hydrogen sulfide toxicity
- Inhalant abuse
- Methane toxicity
- Smoke inhalation injury
- Ethylene dibromide toxicity
Evaluation
Workup
- ECG: assess for QT prolongation, PVCs, ventricular arrhythmias
- Cardiac monitoring
- Chest X-ray if respiratory symptoms are present
- Basic labs:
- CBC, BMP, troponin
- Creatinine kinase (CK)
- ABG if hypoxia suspected
- Urine toxicology screen: may not detect difluoroethane but can help rule out co-ingestions
Diagnosis
- Consider DFE toxicity in any young patient with sudden unexplained arrhythmia, altered mental status, or seizure
- Ask about recent use of aerosol sprays, cleaning products, or refrigerants
- Look for signs of inhalant abuse:
- Chemical odor on breath
- Perioral or hand burns
- Empty aerosol cans
- Skin frostbite
Management
Supportive Care
- Airway, breathing, circulation (ABCs)
- Supplemental oxygen as needed
- Continuous cardiac monitoring due to risk of arrhythmia
- Avoid catecholamines (e.g., epinephrine, norepinephrine) unless absolutely necessary—may precipitate fatal arrhythmias
Treat Complications if Applicable
- Ventricular arrhythmias → defibrillation, amiodarone (avoid lidocaine in some cases)
- Seizures → benzodiazepines
- Respiratory failure or chemical pneumonitis → consider intubation and supportive ventilation
- Skin or mucosal injury → treat as chemical burns or frostbite
Disposition
Admission
- Persistent arrhythmias or EKG abnormalities
- Seizure activity
- Altered mental status or respiratory compromise
- Suspicion of recurrent or chronic use (requires observation)
Discharge
- Normal mental status
- Normal EKG and cardiac monitoring for at least 4–6 hours post-exposure
- No signs of pulmonary or neurologic complications
Referral Considerations
- Substance abuse counseling or addiction medicine
- Consider social work consult for adolescents or vulnerable individuals
- Outpatient follow-up with primary care or mental health services
